High risk of autoimmune diseases after COVID-19

The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Chetan, Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096101/
https://www.ncbi.nlm.nih.gov/pubmed/37046064
http://dx.doi.org/10.1038/s41584-023-00964-y
_version_ 1785024242481364992
author Sharma, Chetan
Bayry, Jagadeesh
author_facet Sharma, Chetan
Bayry, Jagadeesh
author_sort Sharma, Chetan
collection PubMed
description The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases.
format Online
Article
Text
id pubmed-10096101
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100961012023-04-14 High risk of autoimmune diseases after COVID-19 Sharma, Chetan Bayry, Jagadeesh Nat Rev Rheumatol News & Views The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that SARS-CoV-2 infection is linked to a substantially increased risk of developing a diverse spectrum of new-onset autoimmune diseases. Nature Publishing Group UK 2023-04-12 /pmc/articles/PMC10096101/ /pubmed/37046064 http://dx.doi.org/10.1038/s41584-023-00964-y Text en © Springer Nature Limited 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News & Views
Sharma, Chetan
Bayry, Jagadeesh
High risk of autoimmune diseases after COVID-19
title High risk of autoimmune diseases after COVID-19
title_full High risk of autoimmune diseases after COVID-19
title_fullStr High risk of autoimmune diseases after COVID-19
title_full_unstemmed High risk of autoimmune diseases after COVID-19
title_short High risk of autoimmune diseases after COVID-19
title_sort high risk of autoimmune diseases after covid-19
topic News & Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096101/
https://www.ncbi.nlm.nih.gov/pubmed/37046064
http://dx.doi.org/10.1038/s41584-023-00964-y
work_keys_str_mv AT sharmachetan highriskofautoimmunediseasesaftercovid19
AT bayryjagadeesh highriskofautoimmunediseasesaftercovid19

Ejemplares similares